A Novel Perspective on PCSK9 in Alzheimer's Disease: A Focus on Amyloid Beta

This study focuses on the effects of PCSK9 on Aβ accumulation in the brain via multiple modalities to explore the potential role of PCSK9 in AD, which is characterized by progressive loss of brain cells by increasing Aβ accumulation. The study also explores the new mechanism by which PCSK9 is involved in the pathogenesis of AD, providing interesting and innovative guidance for the future of PCSK9-targeted therapy for AD.PMID:38549537 | DOI:10.2174/0109298673269288231123095215
Source: Current Medicinal Chemistry - Category: Chemistry Authors: Source Type: research